000048039 000__ 00890nam\a2200409\i\4500
000048039 001__ 48039
000048039 003__ SzGeWIPO
000048039 005__ 20240708150357.0
000048039 006__ m\\\\eo\\d\\\\\\\\
000048039 007__ cr bn |||m|||a
000048039 008__ 230328s2023\\\\nju\\\\\o\\\\\000\0\eng\d
000048039 0247_ $$a10.1111/jwip.12258$$2doi
000048039 035__ $$a(OCoLC)1373642935
000048039 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000048039 041__ $$aeng
000048039 24504 $$aPatents and other conditions of access to vaccines /
000048039 264_1 $$a[Hoboken, New Jersey] :$$bJohn Wiley & Sons Ltd,$$c2023
000048039 300__ $$a1 online resource (pages 41-62)
000048039 336__ $$atext$$2rdacontent
000048039 337__ $$acomputer$$2rdamedia
000048039 338__ $$aonline resource$$bcr$$2rdacarrier
000048039 4901_ $$aJournal Of World Intellectual Property,$$x1747-1796 ;$$v26, 1, 2023
000048039 588__ $$aCrossref
000048039 590__ $$aPublished online: 30-Jan-23
000048039 650_0 $$aPatents.
000048039 650__ $$aScience & Technology$$zCovid-19.
000048039 7001_ $$aArup, Christopher,$$eauthor.
000048039 7001_ $$aPlahe, Jagjit,$$eauthor.
000048039 7731_ $$tJournal of World Intellectual Property$$wJWIP
000048039 830_0 $$aJournal Of World Intellectual Property ;$$v26, 1, 2023.
000048039 85641 $$uhttps://doi.org/10.1111/jwip.12258$$yOnline version
000048039 904__ $$aJournal article
000048039 980__ $$aJWIP